These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 401127)
1. Oxygen consumption levels in breast cancer: an indicator of estrogen receptor values. Bronn DG; Webster DJ; Minton JP Surg Forum; 1978; 29():174-6. PubMed ID: 401127 [No Abstract] [Full Text] [Related]
2. [Level of estrogen receptors in breast tumors: role of ethnic factors]. Baisheva SA; Khan OG; Togaĭbaeva ZI; Baĭmakhasheva AN Vopr Onkol; 2001; 47(2):205-8. PubMed ID: 11383458 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648 [TBL] [Abstract][Full Text] [Related]
4. Receptor potency estimate: a more reliable indicator of prognosis than estrogen receptor levels. Bowie LJ; Cafaro AF Ann Clin Lab Sci; 1987; 17(2):93-100. PubMed ID: 3579213 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor content in primary breast carcinomas and their metastases. Tani E; Nordenskjöld B; Humla S; Skoog L Anticancer Res; 1988; 8(1):169-71. PubMed ID: 3358632 [TBL] [Abstract][Full Text] [Related]
6. [Steroid receptors and breast carcinoma]. Pasić R; Dulbegović B; Softić D; Wittlif JL Med Pregl; 1991; 44(1-2):48-51. PubMed ID: 1870463 [TBL] [Abstract][Full Text] [Related]
7. Study of the role of steroid receptors in human breast cancer. Tsyrlina EV; Semiglazov VP; Moiseenko VM; Bornoeva TP Neoplasma; 1985; 32(4):463-7. PubMed ID: 4047257 [TBL] [Abstract][Full Text] [Related]
8. [Oestrogen receptors and prognosis in breast cancer]. Rainer H; Bettelheim P; Bieglmayer C; Chaput B; Jakesz R; Kees A; Kolb R; Mörz R; Moser K; Reiner G; Schemper M; Spona J Wien Klin Wochenschr; 1980 Nov; 92(22):796-803. PubMed ID: 7467359 [TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. Neven P; Pochet N; Drijkoningen M; Amant F; De Smet F; Paridaens R; Christiaens MR; Vergote I J Clin Oncol; 2006 Jun; 24(16):2595; author reply 2595-7. PubMed ID: 16735717 [No Abstract] [Full Text] [Related]
10. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. McCafferty MP; McNeill RE; Miller N; Kerin MJ Breast Cancer Res Treat; 2009 Aug; 116(3):425-32. PubMed ID: 19507020 [TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer. Kim HJ; Cui X; Hilsenbeck SG; Lee AV Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118 [TBL] [Abstract][Full Text] [Related]
12. The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm. Lopez-Tarruella S; Schiff R Clin Cancer Res; 2007 Dec; 13(23):6921-5. PubMed ID: 18056165 [No Abstract] [Full Text] [Related]
13. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Ariazi EA; Clark GM; Mertz JE Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of oestrogen receptor beta in breast cancer. Speirs V; Kerin MJ Br J Surg; 2000 Apr; 87(4):405-9. PubMed ID: 10759732 [TBL] [Abstract][Full Text] [Related]
15. The importance of estrogen and progesterone receptor in primary breast cancer. Clark GM; McGuire WL; Hubay CA; Pearson OH; Carter AC Prog Clin Biol Res; 1983; 132E():183-90. PubMed ID: 6647468 [No Abstract] [Full Text] [Related]
16. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. Romić-Stojković R; Gamulin S Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy. Chrapusta SJ; Giermek J; Pieńkowski T Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598 [TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor analysis in early cancer of the breast. Missotten F Ann R Coll Surg Engl; 1982 Sep; 64(5):353-4. PubMed ID: 7114776 [No Abstract] [Full Text] [Related]
19. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. Rizzo P; Osipo C; Pannuti A; Golde T; Osborne B; Miele L Adv Enzyme Regul; 2009; 49(1):134-41. PubMed ID: 19344631 [No Abstract] [Full Text] [Related]
20. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer. Jones LW; Haykowsky M; Pituskin EN; Jendzjowsky NG; Tomczak CR; Haennel RG; Mackey JR Oncologist; 2007 Oct; 12(10):1156-64. PubMed ID: 17962609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]